Cargando…
A prospective observational study to evaluate the safety of COVID-19 mRNA vaccines administered to Qatar Rehabilitation Institute patients
Background: The safety of the COVID-19 mRNA vaccine in the outpatient setting has been extensively studied; however, there need to be more reports that specifically assess their safety in the inpatient population. It is hence imperative to explore the adverse drug reaction (ADR) profile in this popu...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
HBKU Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979845/ https://www.ncbi.nlm.nih.gov/pubmed/36874588 http://dx.doi.org/10.5339/qmj.2023.10 |
_version_ | 1784899800576032768 |
---|---|
author | Noureddine, Zahra Madi, Lama Ullah, Sami Alrawashdeh, Haneen Naseralallah, Lina |
author_facet | Noureddine, Zahra Madi, Lama Ullah, Sami Alrawashdeh, Haneen Naseralallah, Lina |
author_sort | Noureddine, Zahra |
collection | PubMed |
description | Background: The safety of the COVID-19 mRNA vaccine in the outpatient setting has been extensively studied; however, there need to be more reports that specifically assess their safety in the inpatient population. It is hence imperative to explore the adverse drug reaction (ADR) profile in this population and monitor the progression of these ADRs in a hospital setting. This provides a unique opportunity to closely observe patients to ensure no side effects go undiagnosed. This study aims to explore and quantify the incidence and severity of ADRs in patients who have received the COVID-19 vaccine during their stay in the rehabilitation facility. Methods: This is a prospective observational study, which included adult patients admitted to the rehabilitation facility who were deemed eligible to receive the COVID-19 vaccine during their hospital stay. Data were collected by the investigators from June 2021 to May 2022 at 24 hours, 48 hours, and 7 days post-vaccination. A piloted data collection tool was utilized. Results: Thirty-five patients met the inclusion criteria. Pain at the injection site was the most commonly reported local ADR, while headache was the most frequent systemic ADR. The majority of the reported ADRs were mild to moderate in nature, with only one severe reaction detected. Although no statistical significance was noted among the variables, common patterns were identified, such as a higher occurrence of fever at 24 hours after the second dose as opposed to the first dose. Close monitoring of the included study subjects did not reveal any unanticipated ADRs or an increase in ADRs susceptibility and severity compared to the general population. Conclusion: This study supports the initiation of vaccination campaigns in inpatient rehabilitation settings. This approach would offer the advantage of gaining full immunity and reducing the risk of contracting COVID-19 infection and complications once discharged. |
format | Online Article Text |
id | pubmed-9979845 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | HBKU Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-99798452023-03-03 A prospective observational study to evaluate the safety of COVID-19 mRNA vaccines administered to Qatar Rehabilitation Institute patients Noureddine, Zahra Madi, Lama Ullah, Sami Alrawashdeh, Haneen Naseralallah, Lina Qatar Med J Research Paper Background: The safety of the COVID-19 mRNA vaccine in the outpatient setting has been extensively studied; however, there need to be more reports that specifically assess their safety in the inpatient population. It is hence imperative to explore the adverse drug reaction (ADR) profile in this population and monitor the progression of these ADRs in a hospital setting. This provides a unique opportunity to closely observe patients to ensure no side effects go undiagnosed. This study aims to explore and quantify the incidence and severity of ADRs in patients who have received the COVID-19 vaccine during their stay in the rehabilitation facility. Methods: This is a prospective observational study, which included adult patients admitted to the rehabilitation facility who were deemed eligible to receive the COVID-19 vaccine during their hospital stay. Data were collected by the investigators from June 2021 to May 2022 at 24 hours, 48 hours, and 7 days post-vaccination. A piloted data collection tool was utilized. Results: Thirty-five patients met the inclusion criteria. Pain at the injection site was the most commonly reported local ADR, while headache was the most frequent systemic ADR. The majority of the reported ADRs were mild to moderate in nature, with only one severe reaction detected. Although no statistical significance was noted among the variables, common patterns were identified, such as a higher occurrence of fever at 24 hours after the second dose as opposed to the first dose. Close monitoring of the included study subjects did not reveal any unanticipated ADRs or an increase in ADRs susceptibility and severity compared to the general population. Conclusion: This study supports the initiation of vaccination campaigns in inpatient rehabilitation settings. This approach would offer the advantage of gaining full immunity and reducing the risk of contracting COVID-19 infection and complications once discharged. HBKU Press 2023-03-01 /pmc/articles/PMC9979845/ /pubmed/36874588 http://dx.doi.org/10.5339/qmj.2023.10 Text en © 2023 Noureddine, Madi, Ullah, Alrawashdeh, Naseralallah, licensee HBKU Press. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution license CC BY 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Paper Noureddine, Zahra Madi, Lama Ullah, Sami Alrawashdeh, Haneen Naseralallah, Lina A prospective observational study to evaluate the safety of COVID-19 mRNA vaccines administered to Qatar Rehabilitation Institute patients |
title | A prospective observational study to evaluate the safety of COVID-19 mRNA vaccines administered to Qatar Rehabilitation Institute patients |
title_full | A prospective observational study to evaluate the safety of COVID-19 mRNA vaccines administered to Qatar Rehabilitation Institute patients |
title_fullStr | A prospective observational study to evaluate the safety of COVID-19 mRNA vaccines administered to Qatar Rehabilitation Institute patients |
title_full_unstemmed | A prospective observational study to evaluate the safety of COVID-19 mRNA vaccines administered to Qatar Rehabilitation Institute patients |
title_short | A prospective observational study to evaluate the safety of COVID-19 mRNA vaccines administered to Qatar Rehabilitation Institute patients |
title_sort | prospective observational study to evaluate the safety of covid-19 mrna vaccines administered to qatar rehabilitation institute patients |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979845/ https://www.ncbi.nlm.nih.gov/pubmed/36874588 http://dx.doi.org/10.5339/qmj.2023.10 |
work_keys_str_mv | AT noureddinezahra aprospectiveobservationalstudytoevaluatethesafetyofcovid19mrnavaccinesadministeredtoqatarrehabilitationinstitutepatients AT madilama aprospectiveobservationalstudytoevaluatethesafetyofcovid19mrnavaccinesadministeredtoqatarrehabilitationinstitutepatients AT ullahsami aprospectiveobservationalstudytoevaluatethesafetyofcovid19mrnavaccinesadministeredtoqatarrehabilitationinstitutepatients AT alrawashdehhaneen aprospectiveobservationalstudytoevaluatethesafetyofcovid19mrnavaccinesadministeredtoqatarrehabilitationinstitutepatients AT naseralallahlina aprospectiveobservationalstudytoevaluatethesafetyofcovid19mrnavaccinesadministeredtoqatarrehabilitationinstitutepatients AT noureddinezahra prospectiveobservationalstudytoevaluatethesafetyofcovid19mrnavaccinesadministeredtoqatarrehabilitationinstitutepatients AT madilama prospectiveobservationalstudytoevaluatethesafetyofcovid19mrnavaccinesadministeredtoqatarrehabilitationinstitutepatients AT ullahsami prospectiveobservationalstudytoevaluatethesafetyofcovid19mrnavaccinesadministeredtoqatarrehabilitationinstitutepatients AT alrawashdehhaneen prospectiveobservationalstudytoevaluatethesafetyofcovid19mrnavaccinesadministeredtoqatarrehabilitationinstitutepatients AT naseralallahlina prospectiveobservationalstudytoevaluatethesafetyofcovid19mrnavaccinesadministeredtoqatarrehabilitationinstitutepatients |